Prophecy Market Insights: Precision Medicine Market Witnessing Rapid Expansion, Projected To Reach Us$ 168.8 Billion By 2032, Supported By 12.9% Cagr

Precision Medicine is a personalized approach to medicine that uses information from a patient’s genes to diagnose, prevent, and treat disease. The market for Precision Medicine is expected to grow significantly over the next decade due to the growing prevalence of cancer diseases, favorable government policies, and the adoption of advanced technologies such as high-density microarray and NGS (next-generation sequencing). Johns Hopkins launched new precision medicine tools in May 2019 to help clinicians access resources and experts to conduct big data research to improve patient care. Key players in the market include Intomics, GENinCode, NanoString, Novartis AG, Intomics A/S, Ferrer Incode SL, Nanostring Technologies, Inc., Pfizer, Inc., and Teva Pharmaceutica.